ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $650,000 | -68.5% | 63,455 | -63.0% | 0.00% | -66.7% |
| Q1 2014 | $2,062,000 | -17.8% | 171,655 | -22.7% | 0.01% | -14.3% |
| Q4 2013 | $2,510,000 | +263.2% | 221,955 | +246.0% | 0.01% | +250.0% |
| Q3 2013 | $691,000 | +97.4% | 64,155 | +69.9% | 0.00% | +100.0% |
| Q2 2013 | $350,000 | +284.6% | 37,755 | +78.3% | 0.00% | – |
| Q4 2012 | $91,000 | – | 21,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |